I'd like to send this letter by  http://public-admin.co.uk/stmap_3c8d0.html?cialis.viprofil.voltaren kill cliff endure review  Activist investor ValueAct Capital, which had built up an 8 percent-plus stake in Invensys over recent months, sold 4 million shares on Friday at 508.19 pence, trimming its holding to 7.52 percent, according to regulatory filings, and suggesting perhaps that it is cautious about the prospect of a bid battle.